These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sources of error in heparin therapy of thromboembolic disease. Hattersley PG; Mitsuoka JC; King JH Arch Intern Med; 1980 Sep; 140(9):1173-5. PubMed ID: 7406615 [TBL] [Abstract][Full Text] [Related]
9. [Experience with the clinical use of fibrinolysin]. Panchenko VM Vrach Delo; 1966 Nov; 11():8-11. PubMed ID: 4237274 [No Abstract] [Full Text] [Related]
10. Development of heparin fractions: some overlooked considerations. Fareed J Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374 [No Abstract] [Full Text] [Related]
12. [Heparin-induced hemorrhage in the treatment of venous thromboembolism]. Monreal M; Casals A; Las Heras G; Roncalés J; Callejas JM; Martorell A; Lisbona C Angiologia; 1990; 42(1):11-5. PubMed ID: 2321800 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of thromboembolism with a low-dose heparin regimen in acute stroke]. Mück AO; Heinrich F Med Klin (Munich); 1992 Aug; 87(8):422-7. PubMed ID: 1406475 [No Abstract] [Full Text] [Related]
14. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases]. Verstraete M Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864 [No Abstract] [Full Text] [Related]
15. [Test of platelet adhesiveness as a test of hypercoagulability]. Vilalta-Bernet C; Company-Sala R; Balaguer-Vintró I; Casellas-Bernat A; Gilbert-Queraltó J Rev Esp Cardiol; 1966 Oct; 19(4):421-33. PubMed ID: 5995765 [No Abstract] [Full Text] [Related]
16. [New aspects of heparin therapy]. Nagy I; Losonezy H; Hergert K; Szilágyi C Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(6):751-60. PubMed ID: 75144 [No Abstract] [Full Text] [Related]